Cooper Companies | COO - الربح قبل الضريبة

سعر السهم
61.34
التغيير اليومي
-1.75 -2.77%
شهريا
-11.50%
سنويا
-24.89%
Q2 التوقعات
63.04




الربح قبل الضريبة تغيير تاريخ
Abbott USD 2.39B 27M 2026-03
Align Technology USD 176.6M 81.86M 2025-12
AtriCure USD 2.36M 2.45M 2025-12
Avanos Medical USD -1.2M 74.7M 2025-09
Bausch Health Companies USD 56M 162M 2025-12
Baxter International USD 121M 12M 2025-09
Bayer EUR -1.16B 735M 2025-09
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 700M 238M 2025-12
Cooper Companies USD 116.8M 137.4M 2025-09
Dentsply International USD -230M 77M 2025-09
Dexcom USD 300M 58.9M 2025-09
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Globus Medical USD 143.99M 44.18M 2025-09
Haemonetics USD 59.97M 8.69M 2025-12
Inogen USD -6.06M 467K 2024-09
Insulet USD 140.2M 17.4M 2025-12
Integra LifeSciences USD -6.82M 524.13M 2025-09
Intuitive Surgical USD 955.6M 100.4M 2025-12
J&J USD 7.82B 2.86B 2026-03
Medtronic USD 2.1B 224M 2025-09
Merit Medical Systems USD 73.18M 29.8M 2025-09
Novartis USD 5.17B 637M 2025-09
ResMed USD 482.38M 2.51M 2025-09
STAAR Surgical USD 18.79M 44.7M 2025-09
Steris USD 324.4M 92.5M 2025-09
Stryker USD 1.03B 13M 2025-09
Tandem Diabetes Care USD -25.14M 32.58M 2025-09
Teleflex USD -438.58M 573.82M 2025-09
Utah Medical Products 418K 3K 2024-09
Zimmer Biomet Holdings USD 98M 320.7M 2025-12